Development of life-threatening thrombocytopaenia in a patient on MDT and prednisolone.
Croft
R
R
Cross
R
R
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004844:Epistaxis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced*
D000893:Anti-Inflammatory Agents; D007917:Leprostatic Agents; D011239:Prednisolone; D012293:Rifampin